FOXP3 and cancer: We used ImmunoProfile to prospectively capture and quantify four key biomarkers associated with an active (CD8 and PD-1) and suppressed (FOXP3 and PD-L1) immune response in FFPE tissues from 2,023 patients presenting to a tertiary care cancer center over 3.25 years.